Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Voyager Therapeutics (VYGR) Interest Expenses (2016)

Voyager Therapeutics' Interest Expenses history spans 2 years, with the latest figure at -$283000.0 for Q2 2016.

  • For Q2 2016, Interest Expenses fell 293.06% year-over-year to -$283000.0; the TTM value through Mar 2017 reached -$283000.0, up 53.61%, while the annual FY2015 figure was $9.4 million, 383.22% up from the prior year.
  • Interest Expenses for Q2 2016 was -$283000.0 at Voyager Therapeutics, down from -$279000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $9.7 million in Q1 2015 and bottomed at -$283000.0 in Q2 2016.